Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 50, Issue 1, 2009, Pages 101-108

  Nagel, Stefan ^a   Venturini, Letizia ^b   Przybylski, Grzegorz K ^c   Grabarczyk, Piotr ^d   Schmidt, Christian A ^d   Meyer, Corinna ^a   Drexler, Hans G ^a   MacLeod, Roderick A F ^a   Scherr, Michaela ^b  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUTE OF HUMAN GENETICS   (Poland)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

C13orf25; E2F1; miR 17 92; NKX2 5; TLX1; TLX3

Indexed keywords

ETOPOSIDE; HOMEODOMAIN PROTEIN; MICRORNA; MICRORNA 17 92; NUCLEIC ACID BINDING PROTEIN; PROTEIN TLX1; PROTEIN TLX3; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CISTRON; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE CLUSTER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL LINE; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; T CELL LEUKEMIA; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL LINE; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; KILLER CELLS, NATURAL; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICRORNAS;

EID: 59249099105     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802626632     Document Type: Article

References (41)

1. De Robertis, E. M. (1994) The homeobox in cell differentiation and evolution. Guidebook to the Homeobox Genes, pp. 13-23. Oxford University Press, Oxford
2. Cillo, C., Cantile, M., Faiella, A. and Boncinelli, E. (2001) Homeobox genes in normal and malignant cells. J Cell Physiol, 188, pp. 161-169.
3. Abate-Shen, C. (2002) Deregulated homeobox gene expression in cancer: cause or consequence?. Nat Rev Cancer, 10, pp. 777-785.
4. Soulier, J., Clappier, E., Cayuela, J. M., Regnault, A., Garcia-Peydro, M. Dombret, H. et al. (2005) HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood, 106, pp. 274-286.
5. Holland, P. W. (2001) Beyond the Hox: How widespread is homeobox gene clustering?. J Anat, 199, pp. 13-23.
6. Hatano, M., Roberts, C. W., Minden, M., Crist, W. M. and Korsmeyer, S. J. (1991) Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science, 253, pp. 79-82.
7. Bernard, O. A., Busson-LeConiat, M., Ballerini, P., Mauchauffe, M., Della Valle, V. Monni, R. et al. (2002) A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia, 15, pp. 1495-1504.
8. Nagel, S., Kaufmann, M., Drexler, H. G. and MacLeod, R. A. (2003) The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res, 63, pp. 5329-5334.
9. Hansen-Hagge, T. E., Schafer, M., Kiyoi, H., Morris, S. W., Whitlock, J. A. Koch, P. et al. (2002) Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia, 16, pp. 2205-2212.
10. MacLeod, R. A., Nagel, S., Kaufmann, M., Janssen, J. W. and Drexler, H. G. (2003) Activation of HOX11L2 by juxtaposition with 3′-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer, 37, pp. 84-91.
11. Przybylski, G. K., Dik, W. A., Grabarczyk, P., Wanzeck, J., Chudobska, P. Jankowski, K. et al. (2006) The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. Haematologica, 91, pp. 317-321.
12. Su, X. Y., Della-Valle, V., Andre-Schmutz, I., Lemercier, C., Radford-Weiss, I. Ballerini, P. et al. (2006) HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood, 108, pp. 4198-4201.
13. Nagel, S., Scherr, M., Kel, A., Hornischer, K., Crawford, G. E. Kaufmann, M. et al. (2007) Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res, 67, pp. 1461-1471.
14. Kawabe, T., Muslin, A. J. and Korsmeyer, S. J. (1997) HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature, 385, pp. 454-458.
15. Ferrando, A. A. and Look, A. T. (2003) Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol, 40, pp. 274-280.
16. Hoffmann, K., Dixon, D. N., Greene, W. K., Ford, J., Taplin, R. and Kees, U. R. (2004) A microarray model system identifies potential new target genes of the proto-oncogene HOX11. Genes Chromosomes Cancer, 41, pp. 309-320.
17. Riz, I. and Hawley, R. G. (2005) G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia. Oncogene, 24, pp. 5561-5575.
18. Nagel, S., Meyer, C., Quentmeier, H., Kaufmann, M., Drexler, H. G. and Macleod, R. A. (2008) MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia, 22, pp. 600-607.
19. Venturini, L., Eder, M. and Scherr, M. (2006) RNA-Mediated gene silencing in hematopoietic cells. J Biomed Biotechnol, 2006, pp. 1-13.
20. Bushati, N. and Cohen, S. M. (2007) MicroRNA functions. Annu Rev Cell Dev Biol, 23, pp. 175-205.
21. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J. Peck, D. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, pp. 834-838.
22. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T. Manoharan, M. et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, pp. 685-689.
23. Scherr, M., Venturini, L., Battmer, K., Schaller-Schoenitz, M., Schaefer, D. Dallmann, I. et al. (2007) Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res, 35, p. e149.
24. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. and Burge, C. B. (2003) Prediction of mammalian microRNA targets. Cell, 115, pp. 787-798.
25. Wang, X., Gjorloff-Wingren, A., Saxena, M., Pathan, N., Reed, J. C. and Mustelin, T. (2000) The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase. J Immunol, 164, pp. 1934-1939.
26. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. and Mendell, J. T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, pp. 839-843.
27. Phillips, A. C. and Vousden, K. H. (2001) E2F-1 induced apoptosis. Apoptosis, 6, pp. 173-182.
28. Hallstrom, T. C., Mori, S. and Nevins, J. R. (2008) An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell, 13, pp. 11-22.
29. Starr, T. K., Jameson, S. C. and Hogquist, K. A. (2003) Positive and negative selection of T cells. Annu Rev Immunol, 21, pp. 139-176.
30. De Keersmaecker, K., Marynen, P. and Cools, J. (2005) Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica, 90, pp. 1116-1127.
31. Field, S. J., Tsai, F. Y., Kuo, F., Zubiaga, A. M., Kaelin Jr, W. G. Livingston, D. M. et al. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85, pp. 549-561.
32. Garcia, I., Murga, M., Vicario, A., Field, S. J. and Zubiaga, A. M. (2000) A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ, pp. 1191-1198.
33. Drexler, H. G. (2005) Guide to leukemia-lymphoma cell lines. Braunschweig
34. Venturini, L., Battmer, K., Castoldi, M., Schultheis, B., Hochhaus, A. Muckenthaler, M. U. et al. (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood, 109, pp. 4399-4405.
35. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. and Dowdy, S. F. (2000) A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature, 407, pp. 642-645.
36. Bi, B., Littlewood, N. K. and Crispe, I. N. (2001) Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes. Immunology, 104, pp. 37-42.
37. Cao, Q., Xia, Y., Azadniv, M. and Crispe, I. N. (2004) The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J Immunol, 173, pp. 1111-1117.
38. Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B. Wang, J. et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol, 9, pp. 405-414.
39. Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A. Erkeland, S. J. et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 132, pp. 875-886.
40. Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C. Raimondi, S. C. et al. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1, pp. 75-87.
41. Ballerini, P., Blaise, A., Busson-Le Coniat, M, Su, X. Y., Zucman-Rossi, J. Adam, M. et al. (2002) HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood, 100, pp. 991-997.